Listed

Claritev Corp: Form 10-Q for the period ended Sep 30, 2023

Filed with the SEC on Nov 8, 2023 and accepted by EDGAR at Nov 8, 2023, 08:01 ET.

Share

Management's discussion and analysis

As filed, 60,512 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of the Company’s financial condition and results should be read in conjunction with the unaudited condensed consolidated financial statements and accompanying notes thereto contained elsewhere in this Quarterly Report and together with the information included in the Company’s 2022 Annual Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties; the results described below are not necessarily indicative of the results to be expected in any future periods.

Cautionary Note Regarding Forward-looking Statements

All statements other than statements of historical fact included in this Quarterly Report including, without limitation, statements under this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 or Section 21E of the Securities Exchange Act of 1934, each as amended, including, in particular, statements about our plans, strategies and prospects as well as estimates of industry growth for the next quarter and beyond. When used in this Quarterly Report, words such as “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will” or “should” or, in each case, their negative or other variations or comparable terminology represent forward-looking statements that include matters that are not historical facts. They may appear in a number of places throughout this Quarterly Report and these forward-looking statements reflect management’s expectations regarding our future growth, results of operations, operational and financial performance and business prospects and opportunities. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting our business. Factors that may impact such forward-looking statements include:

  • loss of our customers, particularly our largest customers;
  • trends in the U.S. healthcare system, including recent trends of unknown duration of reduced healthcare utilization and increased patient financial responsibility for services;
  • inability to preserve or increase our existing market share or the size of our PPO networks;
  • effects of competition;
  • effects of pricing pressure;
  • the inability of our customers to pay for our services;
  • decreases in discounts from providers;
  • the loss of our existing relationships with providers;
  • the loss of key members of our management team or inability to maintain sufficient qualified personnel;
  • pressure to limit access to preferred provider networks;
  • the ability to achieve the goals of our strategic plans and recognize the anticipated strategic, operational, growth and efficiency benefits when expected;
  • our ability to enter new lines of business and broaden the scope of our services;
  • our ability to identify, complete and successfully integrate acquisitions;
  • our ability to obtain additional financing;
  • changes in our industry and in industry standards and technology;
  • interruptions or security breaches of our information technology systems and other cyber security attacks;
  • our ability to protect proprietary information, processes and applications;
  • our ability to maintain the licenses or right of use for the software we use;
  • our inability to expand our network infrastructure;
  • changes in our accounting principles or the incurrence of impairment charges;
  • our ability to remediate any material weaknesses or maintain effective internal controls over financial reporting;
  • our ability to continue to attract, motivate and retain a large number of skilled employees, and adapt to the effects of inflationary pressure on wages;
  • changes in our regulatory environment, including healthcare law and regulations;
  • the expansion of privacy and security laws;
  • heightened enforcement activity by government agencies;
  • our ability to pay interest and principal on our notes and other indebtedness;
  • lowering or withdrawal of our credit ratings;
  • the possibility that we may be adversely affected by other political, economic, business, and/or competitive factors;
  • adverse outcomes related to litigation or governmental proceedings;
  • other factors disclosed in this Quarterly Report; and
  • other factors beyond our control.

The forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors referred to under the heading “Risk Factors” in Part II, Item 1A of this Quarterly Report or as described in our 2022 Annual Report. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Company Overview

MultiPlan is a leading provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency and fairness to the U.S. healthcare industry. We do so through services focused on reducing medical cost and improving payment accuracy for the Payors of healthcare, which are primarily health insurers, self-insured employers, federal and state government-sponsored health plans and other health plan sponsors (typically through their health plan administrators), and, indirectly, the plan members who are the consumers of healthcare services.

MultiPlan was founded in 1980 as a New York-based hospital network and has evolved both organically and through acquisition into an integrated data and analytics platform offering a suite of services, which efficiently address the cost of medical services. MultiPlan offers services to our customers in three categories:

  • Analytics-Based Services: a suite of data-driven algorithms and insights that detect claims over-charges and either negotiate or recommend fair reimbursement for out-of-network medical costs using a variety of data sources and pricing algorithms. These services are applied prior to the payment of the claim and are often processed within a day of receipt;
  • Network-Based Services: contracted discounts with healthcare providers to form one of the largest independent preferred provider organizations ("PPO") in the United States with over 1.3 million providers under contract, as well as outsourced network development and/or management services. These services are applied prior to the payment of the claim and are typically processed within a day of receipt; and
  • Payment and Revenue Integrity Services: data, technology, and clinical expertise deployed to identify and remove improper and unnecessary charges before or after claims are paid, or to identify and help restore and preserve underpaid premium dollars.

MultiPlan sits at the nexus of four constituencies (Payors, employers/plan sponsors, plan members and providers) and offers an independent reimbursement solution to reduce healthcare costs in a manner that is systematic, efficient and fair to all parties involved. Although the end beneficiaries of our services are employers and other plan sponsors and their health plan members, our direct customers are typically health plan administrators ("Payors") who go out to market with our services. Over the last 40+ years, we have developed a platform that offers these Payors a single interface to a comprehensive set of services, which are used in combination or individually to reduce the medical cost burden on their health plan customers and members while fostering independently developed fair and efficient reimbursements to healthcare providers. These comprehensive offerings have enabled us to maintain long-term relationships with a number of our customers, including relationships of over 25 years with some of the nation's largest Payors. For the nine months ended September 30, 2023 and year ended December 31, 2022, our comprehensive services identified approximately $17.0 billion and $22.3 billion in potential medical cost savings, respectively.

We believe our solutions provide a strong value proposition to Payors, their health plan customers and healthcare consumers, as well as to providers. Overall, our service offerings aim to reduce healthcare costs in a manner that is orderly, efficient and fair to all parties. In addition, because in most instances the fee for our services is directly linked to the savings we identify, our revenue model is aligned with the interests of our customers.

Factors Affecting Our Results of Operations

BST Acquisition

On May 8, 2023, the Company acquired BST, a company offering next generation data and advanced analytics services. The financial results of BST are contained in our Analytics-Based Services service line.

Through September 30, 2023, BST's impact on revenues, net earnings, and results of operations was not material.

Medical Cost Savings

Our business and revenues are driven by the ability to lower medical costs through claims savings for our customers. The medical charges of those claims can influence our ability to generate claim savings.

The following table presents the medical charges processed and the potential savings identified for the periods presented:

Three Months Ended September 30, Change Nine Months Ended September 30, Change
(in billions) 2023 2022% 2023 2022
Commercial Health Plans
Medical charges processed $18.5 $17.9 3.4% $55.6 $56.1 (0.9)%
Potential medical cost savings $5.5 $5.1 7.8% $16.1 $16.1 —%
Potential savings as a % of charges 29.5% 28.6% 28.9% 28.6%
Payment & Revenue Integrity, Property & Casualty, and Other
Medical charges processed $24.0 $20.8 15.4% $69.7 $60.2 15.8%
Potential medical cost savings $0.3 $0.3 —% $0.9 $0.8 12.5%
Potential savings as a % of charges 1.3% 1.3% 1.3% 1.3%
Total
Medical charges processed $42.5 $38.7 9.8% $125.3 $116.2 7.8%
Potential medical cost savings $5.8 $5.4 7.4% $17.0 $16.9 0.9%
Potential savings as a % of charges 13.6% 14.0% 13.6% 14.5%

Medical charges processed represent the aggregate dollar amount of claims processed by our cost management and payment accuracy solutions in the period presented. The dollar amount of the claim for purposes of this calculation is the dollar amount of the claim prior to any reductions that may be made as a result of the claim being processed by our solutions. The table above does not include any medical charges processed for BST as BST is a fee-based subscription service and there are no medical charges to report relative to their revenues.

Potential medical cost savings represent the aggregate amount of potential savings in dollars identified by our cost management and payment accuracy solutions in the period presented. Since certain of our fees are based on the amount of savings achieved by our customers, and our customers are the final adjudicator of the claims and may choose not to reduce claims or reduce claims by only a portion of the potential savings identified, potential medical cost savings may not directly correlate with the amount of fees earned in connection with the processing of such claims. The table above does not include any potential medical cost savings for BST as BST is a fee-based subscription service and there are no potential medical cost savings to report relative to their revenues.

Components of Results of Operations

Revenues

We generate revenues from several sources including: (i) Network-Based Services that process claims at a discount compared to billed fee-for-service rates and by using an extensive network, (ii) Analytics-Based Services that use our leading and proprietary information technology platform to offer customers solutions to reduce medical costs, and (iii) Payment and Revenue Integrity Services that use data, technology, and clinical expertise to identify improper, unnecessary and excessive charges. Payors typically compensate us through either a PSAV achieved or a PEPM rate.

Costs of Services (exclusive of depreciation and amortization of intangible assets)

Costs of services (exclusive of depreciation and amortization of intangible assets) consist of all costs specifically associated with claims processing activities for customers, sales and marketing, and the development and maintenance of our networks, analytics-based services, and payment and revenue integrity services. Two of the largest components in costs of services are personnel expenses and access and bill review fees. Access and bill review fees include fees for accessing non-owned third-party provider networks, expenses associated with vendor fees for database access and systems technology used to reprice claims, and outsourced services. Third-party network expenses are fees paid to non-owned provider networks used to supplement our owned network assets to provide more network claim savings to our customers.

General and Administrative Expenses

General and administrative expenses include corporate management and governance functions composed of general management, legal, treasury, tax, real estate, financial reporting, auditing, benefits and human resource administration, communications, public relations, billing and information management. In addition, general and administrative expenses include taxes, insurance, advertising, transaction costs, and other general expenses.

Depreciation Expense

Depreciation expense consists of depreciation and amortization of property and equipment related to our investments in leasehold improvements, furniture and equipment, computer hardware and software, and internally generated capitalized software development costs. We provide for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated useful lives.

Amortization of intangible assets

Amortization of intangible assets includes amortization of the value of our customer relationships, provider network, technology, and trademarks which were identified in valuing the intangible assets in connection with the June 6, 2016 acquisition by H&F and its affiliates, as well as the acquisitions of HST and DHP by the Company.

Interest expense

Interest expense consists of accrued interest and related interest payments on our outstanding long-term debt and amortization of debt issuance costs and discounts.

Interest income

Interest income consists primarily of bank interest.

Gain on extinguishment of debt

The Company recognizes a gain on extinguishment of debt for the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt.

Change in fair value of Private Placement Warrants and Unvested Founder Shares

The Company re-measures at each reporting period the fair value of the Private Placement Warrants and Unvested Founder Shares. The changes in fair value are primarily due to the changes in the stock price of the Company's Class A common stock, changes in expected stock volatility and the passage of time.

Income tax (benefit) expense

Income tax (benefit) expense consists of federal, state, and local income taxes.

Non-GAAP Financial Measures

We use EBITDA, Adjusted EBITDA and Adjusted EPS to evaluate our financial performance. EBITDA, Adjusted EBITDA and Adjusted EPS are financial measures that are not presented in accordance with GAAP. We believe the presentation of these non-GAAP financial measures provides useful information to investors in assessing our financial condition and results of operations across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our financial operating results of our core business.

These measurements of financial performance have important limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Additionally, they may not be comparable to other similarly titled measures of other companies. Some of these limitations are:

  • such measures do not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments;
  • such measures do not reflect changes in, or cash requirements for, our working capital needs;
  • such measures do not reflect the significant interest expense, or cash requirements necessary to service interest or principal payments on our debt;
  • such measures do not reflect any cash requirements for any future replacement of depreciated assets;
  • such measures do not reflect the impact of stock-based compensation upon our results of operations;
  • such measures do not reflect our income tax (benefit) expense or the cash requirements to pay our income taxes;
  • such measures do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations; and
  • other companies in our industry may calculate these measures differently from how we do, limiting their usefulness as a comparative measure.

In evaluating EBITDA, Adjusted EBITDA and Adjusted EPS, you should be aware that in the future we may incur expenses similar to those eliminated in the presentation.

EBITDA, Adjusted EBITDA, and Adjusted EPS are widely used measures of corporate profitability eliminating the effects of financing and capital expenditures from the operating results. We define EBITDA as net (loss) income adjusted for interest expense, interest income, income tax expense (benefit), depreciation, amortization of intangible assets, and non-income taxes. We define Adjusted EBITDA as EBITDA further adjusted to eliminate the impact of certain items that we do not consider to be indicative of our core business, including other expenses, net, (gain) loss on change in fair value of Private Placement Warrants and Unvested Founder Shares, transaction related expenses, (gain) loss on debt extinguishment, (gain) loss on investments, and stock-based compensation. See our unaudited condensed consolidated financial statements included in this Quarterly Report for more information regarding these adjustments. Adjusted EBITDA is used in our agreements governing our outstanding indebtedness for debt covenant compliance purposes. Our Adjusted EBITDA calculation is consistent with the definition of Adjusted EBITDA used in our debt instruments.

Adjusted EPS is used in reporting to our Board and executive management and as a component of the measurement of our performance. We believe that this measure provides useful information to investors because it is the profitability measure we use to evaluate earnings performance on a comparable year-to-year basis. Adjusted EPS is defined as net (loss) income adjusted for amortization of intangible assets, stock-based compensation, transaction related expenses, (gain) loss on debt extinguishment, (gain) loss on investments, other expense, (gain) loss on change in fair value of Private Placement Warrants and Unvested Founder Shares and tax effect of adjustments to arrive at Adjusted net income divided by our basic weighted average number of shares outstanding.

The following table presents a reconciliation of net (loss) income to EBITDA and Adjusted EBITDA for the periods presented:

(in thousands)

Three Months Ended September 30, 2023 2022 Nine Months Ended September 30, 2023 2022
Net income (loss) $(24,145) $19,736 $(60,306) $77,226
Adjustments:
Interest expense 84,300 77,087 250,203 221,228
Interest income (1,505) (886) (7,110) (944)
(Benefit) provision for income taxes (6,875) (10,687) (14,977) 10,025
Depreciation 19,586 17,481 56,693 51,248
Amortization of intangible assets 85,971 85,127 256,724 255,408
Non-income taxes 669 76 1,672 1,069
EBITDA $158,001 $187,934 $482,899 $615,260
Adjustments:
Other expenses, net(1) 521 553 759 2,206
Integration expenses 891 1,066 2,722 3,762
Change in fair value of Private Placement Warrants and unvested founder shares (2,127) (48,851) 267 (56,443)
Transaction-related expenses 269 27,408 8,105 31,420
Gain on extinguishment of debt (10,129) — (46,907) —
Gain on investments — — — (289)
Stock-based compensation 4,835 4,064 13,357 11,298
Adjusted EBITDA $152,261 $172,174 $461,202 $607,214

(1) "Other expenses, net" represent miscellaneous non-recurring income, miscellaneous non-recurring expense, gain or loss on disposal of assets, impairment of other assets, gain or loss on disposal of leases, tax penalties, and non-integration related severance costs.

Material differences between MultiPlan Corporation and MPH for the three and nine months ended September 30, 2023 include differences in interest expense, change in fair value of Private Placement Warrants and Unvested Founder Shares, and stock-based compensation. For the three and nine months ended September 30, 2023, interest expense for MultiPlan Corporation was $20.1 million and $61.2 million, respectively, higher than interest expense for MPH due to interest expense incurred by MultiPlan Corporation on the Senior Convertible PIK Notes. The (gain) loss on change in fair value of Private Placement Warrants and Unvested Founder Shares and stock-based compensation are recorded in the parent company MultiPlan Corporation and not in the MPH operating company and therefore the entire amount represents differences between MultiPlan Corporation and MPH. In the three and nine months ended September 30, 2023 and September 30, 2022, EBITDA expenses for MultiPlan Corporation were lower than MPH by $1.0 million and $3.0 million, respectively, primarily due to insurance premiums paid to our captive insurance company, net of related captive insurance company costs, which are eliminated in the consolidated financial reporting of MultiPlan Corporation.

The following table presents a reconciliation of net (loss) income to Adjusted EPS for the periods presented:

(in thousands, except share and per share amounts)

2023 Three Months Ended September 30, 2022 2023 Nine Months Ended September 30, 2022
Net (loss) income $(24,145) $19,736 $(60,306) $77,226
Adjustments:
Amortization of intangible assets 85,971 85,127 256,724 255,408
Other expenses, net 521 553 759 2,206
Integration expenses 891 1,066 2,722 3,762
Change in fair value of Private Placement Warrants and unvested founder shares (2,127) (48,851) 267 (56,443)
Transaction-related expenses 269 27,408 8,105 31,420
Gain on investments — — — (289)
Gain on extinguishment of debt (10,129) — (46,907) —
Stock-based compensation 4,835 4,064 13,357 11,298
Estimated tax effect of adjustments (20,334) (30,557) (58,059) (76,245)
Adjusted net income $35,752 $58,546 $116,662 $248,343
Weighted average shares outstanding – Basic 646,443,806 639,073,949 643,855,782 638,859,792
Net income per share – basic $(0.04) $0.03 $(0.09) $0.12
Adjusted EPS $0.06 $0.09 $0.18 $0.39

Factors Affecting the Comparability of our Results of Operations

As a result of a number of factors, our historical results of operations may not be comparable to our results of operations in future periods and may not be directly comparable from period to period. Set forth below is a brief discussion of the key factors impacting the comparability of our results of operations.

BST Acquisition

On May 8, 2023, the Company acquired BST. The financial results of BST are contained in our Analytics-Based Services service line. The results of operations and financial condition of BST have been included in the Company's consolidated results from the date of acquisition. In connection with the BST acquisition, the Company incurred transaction costs. The transaction costs have been expensed as incurred and these amounts totaling $0.1 million and $6.9 million for the three and nine months ended September 30, 2023, respectively, are included in general and administrative expenses. In addition, certain acquired expenses from the acquisition of BST are included in costs of services and general and administrative expenses for the three and nine months ended September 30, 2023.

Debt Repurchase and Cancellation

During the three months ended September 30, 2023, the Company repurchased and cancelled $46.1 million of the 5.750% Notes, resulting in the recognition of a gain on debt extinguishment of $10.1 million, representing the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt.

During the nine months ended September 30, 2023, the Company repurchased and cancelled $184.0 million of the 5.750% Notes, resulting in the recognition of a gain on debt extinguishment of $46.9 million, representing the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt.

In the year ended December 31, 2022, the Company repurchased in the open market and cancelled $136.2 million of the 5.750% Notes, resulting in the recognition of a gain on extinguishment of debt of $34.6 million.

Floating Rate Debt

Term Loan B has a variable interest rate and as interest rates have increased, our annualized weighted average cash interest rate increased by 0.75% during the three months ended September 30, 2023, as compared to the three months ended September 30, 2022. As of September 30, 2023, our total debt had an annualized weighted average cash interest rate of 6.97%, as compared to 6.22% as of September 30, 2022.

Results of Operations for the Three and Nine Months Ended September 30, 2023 and 2022

The following table provides the results of operations for the periods indicated:

(in thousands)

Revenues Three Months Ended September 30, 2023 2022 Change $% Nine Months Ended September 30, 2023 2022 Change $%
Network-Based Services $56,828 $58,859 $(2,031) (3.5)% $171,171 $190,903 $(19,732) (10.3)%
Analytics-Based Services 158,414 163,922 (5,508) (3.4)% 462,275 553,334 (91,059) (16.5)%
Payment and Revenue Integrity Services 27,562 27,672 (110) (0.4)% 83,943 94,390 (10,447) (11.1)%
Total Revenues $242,804 $250,453 $(7,649) (3.1)% $717,389 $838,627 $(121,238) (14.5)%
Costs of services (exclusive of depreciation and amortization of intangible assets shown below) 60,949 53,012 7,937 15.0% 174,806 150,061 24,745 16.5%
General and administrative expenses 36,779 58,434 (21,655) (37.1)% 107,996 131,107 (23,111) (17.6)%
Depreciation expense 19,586 17,481 2,105 12.0% 56,693 51,248 5,445 10.6%
Amortization of intangible assets 85,971 85,127 844 1.0% 256,724 255,408 1,316 0.5%
Operating income 39,519 36,399 3,120 8.6% 121,170 250,803 (129,633) (51.7)%
Interest expense 84,300 77,087 7,213 9.4% 250,203 221,228 28,975 13.1%
Interest income (1,505) (886) (619) 69.9% (7,110) (944) (6,166) NM
Gain on extinguishment of debt (10,129) — (10,129) NM (46,907) — (46,907) NM
Gain on investments — — — NM — (289) 289 (100.0)%
(Gain) loss on change in fair value of Private Placement Warrants and Unvested Founder Shares (2,127) (48,851) 46,724 (95.6)% 267 (56,443) 56,710 (100.5)%
Net (loss) income before taxes (31,020) 9,049 (40,069) (442.8)% (75,283) 87,251 (162,534) (186.3)%
(Benefit) provision for income taxes (6,875) (10,687) 3,812 (35.7)% (14,977) 10,025 (25,002) (249.4)%
Net (loss) income $(24,145) $19,736 $(43,881) (222.3)% $(60,306) $77,226 $(137,532) (178.1)%

NM = Not meaningful

Revenues

Revenues decreased by $7.6 million, or 3.1%, for the three months ended September 30, 2023, as compared to the three months ended September 30, 2022. This decrease in revenues was due to decreases in Network-Based Services revenues of $2.0 million, Analytics-Based Services revenues of $5.5 million, and Payment and Revenue Integrity Services revenues of $0.1 million during this time period, as explained below.

Revenues decreased by $121.2 million, or 14.5%, for the nine months ended September 30, 2023, as compared to the nine months ended September 30, 2022. This decrease in revenues was due to decreases in Network-Based Services revenues of $19.7 million, Analytics-Based Services revenues of $91.1 million, and Payment and Revenue Integrity Services revenues of $10.4 million during this time period, as explained below.

Revenues from the acquisition of BST of $3.6 million for the three months ended September 30, 2023 and $5.7 million for the nine months ended September 30, 2023 were included in our Analytics-Based Services revenues.

Network-Based Services revenues decreased $2.0 million, or 3.5%, in the three months ended September 30, 2023, as compared to the three months ended September 30, 2022. This decrease in revenues was primarily related to lower medical cost savings on PSAV claims received from customers and contractual rate changes with customers contributing to decreases in Network-Based Services PSAV revenues of $2.8 million, partially offset by increases in PEPM and other network revenues of $0.8 million.

Network-Based Services revenues decreased $19.7 million, or 10.3%, in the nine months ended September 30, 2023, as compared to the nine months ended September 30, 2022. This decrease in revenues was primarily related to lower medical cost savings on PSAV claims received from customers and contractual rate changes with customers contributing to decreases in Network-Based Services PSAV revenues of $21.8 million, partially offset by increases in PEPM and other network revenues of $2.1 million.

Analytics-Based Services revenues decreased $5.5 million, or 3.4%, for the three months ended September 30, 2023, as compared to the three months ended September 30, 2022. This decrease in revenues was primarily due to contractual rate changes with customers contributing to decreases in Analytics-Based Services PSAV revenues of $11.1 million, partially offset by increases in Analytics-Based Services PEPM and other revenues of $5.5 million, including acquired revenues of $3.6 million from the acquisition of BST.

Analytics-Based Services revenues decreased $91.1 million, or 16.5%, for the nine months ended September 30, 2023, as compared to the nine months ended September 30, 2022. This decrease in revenues was primarily due to contractual rate changes with customers contributing to decreases in Analytics-Based Services PSAV revenues of $98.1 million, partially offset by increases in Analytics-Based Services PEPM and other revenues of $7.0 million, including acquired revenues of $5.7 million from the acquisition of BST.

Payment and Revenue Integrity Services revenues were relatively flat for the three months ended September 30, 2023, as compared to the three months ended September 30, 2022. Payment and Revenue Integrity Services revenues decreased by $10.4 million, or 11.1%, for the nine months ended September 30, 2023, as compared to the nine months ended September 30, 2022. This decrease was primarily in our Clinical Negotiations pre-payment integrity line of business, contributing to decreases in PSAV revenues of $10.4 million.

Costs of Services (exclusive of depreciation and amortization of intangible assets)

(in thousands)

Three Months Ended September 30, 2023 2022 Change $% Nine Months Ended September 30, 2023 2022 Change $%
Personnel expenses excluding stock-based compensation $49,426 $43,852 $5,574 12.7% $143,662 $124,621 $19,041 15.3%
Stock-based compensation 1,523 895 628 70.2% 3,940 2,422 1,518 62.7%
Personnel expenses including stock-based compensation 50,949 44,747 6,202 13.9% 147,602 127,043 20,559 16.2%
Access and bill review fees 4,698 4,374 324 7.4% 14,497 12,131 2,366 19.5%
Other costs of services 5,302 3,891 1,411 36.3% 12,707 10,887 1,820 16.7%
Total costs of services $60,949 $53,012 $7,937 15.0% $174,806 $150,061 $24,745 16.5%

The increases in costs of services of $7.9 million, or 15.0%, and $24.7 million, or 16.5% for the three and nine months ended September 30, 2023, as compared to the three and nine months ended September 30, 2022, respectively, were primarily due to increases in personnel expenses from increases in employee headcount and year-over-year increases in compensation and related fringe benefits, as well as acquired costs of services expenses from the acquisition of BST of $1.2 million and $2.3 million during the three and nine months ended September 30, 2023, respectively.

Increases in access and bill review fees for the three and nine months ended September 30, 2023 were primarily due to increases in claims processing expenses as a result of increased volume in related lines of business.

Increases in other costs of services expenses for the three and nine months ended September 30, 2023, as compared to the three and nine months ended September 30, 2022, includes net expense increases in miscellaneous other expenses that are not individually material, including other costs of services from BST.

General and Administrative Expenses

(in thousands)

Three Months Ended September 30, 2023 2022 Change $% Nine Months Ended September 30, 2023 2022 Change $%
General and administrative expenses excluding stock-based compensation and transaction-related expenses $33,198 $27,857 $5,341 19.2% $90,474 $90,811 $(337) (0.4)%
Stock-based compensation 3,312 3,169 143 4.5% 9,417 8,876 541 6.1%
Transaction-related expenses 269 27,408 (27,139) (99.0)% 8,105 31,420 (23,315) (74.2)%
General and administrative expenses $36,779 $58,434 $(21,655) (37.1)% $107,996 $131,107 $(23,111) (17.6)%

The decrease of $21.7 million, or 37.1%, in general and administrative expenses for the three months ended September 30, 2023, as compared to the three months ended September 30, 2022 was primarily due to decreases in transaction costs of $27.1 million, offset by acquired general and administrative expenses from the acquisition of BST of $4.4 million and net increases in other general and administrative expenses of $1.0 million.

The decrease of $23.1 million, or 17.6%, in general and administrative expenses for the nine months ended September 30, 2023, as compared to the nine months ended September 30, 2022 was primarily due to decreases in transactions-related expenses of $23.3 million, decreases in insurance costs of $2.7 million, decreases in personnel expenses of $4.5 million due to higher capitalized development offset, decreases in integration expenses of $1.1 million related to the integration of recently acquired companies including HST, DHP, and BST, and net decreases in general and administrative expenses of $2.4 million, offset by increases in professional fees of $3.2 million, increases in equipment lease and maintenance of $1.8 million, and acquired general and administrative expenses from the acquisition of BST of $5.9 million.

Depreciation Expense

The increase of $2.1 million, or 12.0%, and $5.4 million, or 10.6%, in depreciation expense for the three and nine months ended September 30, 2023 as compared to the three and nine months ended September 30, 2022 were due to purchases of property and equipment, including internally generated capitalized software in the three and nine months ended September 30, 2023 and year-ended December 31, 2022, respectively, partially offset by assets that were written-off or became fully depreciated in the period.

Amortization of Intangible Assets

Amortization of intangible assets was relatively flat for the three and nine months ended September 30, 2023 as compared to the three months ended September 30, 2022.

Interest Expense

The increase in interest expense of $7.2 million, or 9.4%, and $29.0 million, or 13.1% for the three and nine months ended September 30, 2023, as compared to the three and nine months ended September 30, 2022, respectively were primarily due to the increase in the interest rate on our Term Loan B, offset by reductions in interest expense due to the repurchase and cancellation of our 5.750% Notes. Our annualized weighted average cash interest rate increased by 0.75% across our total debt in the nine months ended September 30, 2023 as compared to the same period in prior year.

As of September 30, 2023, our long-term debt was $4,558.0 million and included (i) $1,285.3 million Term Loan B, excluding the current portion of Term Loan B of $13.3 million, (ii) $1,050.0 million of 5.50% Senior Secured Notes, (iii) $979.8 million of 5.750% Notes, (iv) $1,300.0 million of Senior Convertible PIK Notes, and net of (v) discount on Term Loan B of $9.8 million, (vi) discount on Senior Convertible PIK Notes of $20.3 million, and (vii) debt issue costs of $27.0 million. As of September 30, 2023, our total debt had an annualized weighted average cash interest rate of 6.97%. As of September 30, 2022, our total debt had an annualized weighted average cash interest rate of 6.22%.

As of December 31, 2022, our long-term debt was $4,741.9 million and included (i) $1,295.2 million Term Loan B, excluding the current portion of Term Loan B of $13.3 million, (ii) $1,050.0 million of 5.50% Senior Secured Notes, (iii) $1,163.8 million of 5.750% Notes, (iv) $1,300.0 million of Senior Convertible PIK Notes, and net of (v) discount on Term

Loan B of $11.1 million, (vi) discount on Senior Convertible PIK Notes of $23.6 million, and (vii) debt issue costs of $32.4 million. As of December 31, 2022, our total debt had a weighted average cash interest rate of 6.67%.

Gain on extinguishment of debt

During the three months ended September 30, 2023, the Company repurchased and cancelled $46.1 million of the 5.750% Notes, resulting in the recognition of a gain on debt extinguishment of $10.1 million, representing the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt.

During the nine months ended September 30, 2023, the Company repurchased and cancelled $184.0 million of the 5.750% Notes, resulting in the recognition of a gain on debt extinguishment of $46.9 million, representing the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt.

Change in fair value of Private Placement Warrants and Unvested Founder Shares

The Company re-measures the fair value of the Private Placement Warrants and Unvested Founder Shares at each reporting period. From December 31, 2022 to September 30, 2023, the fair value of the Private Placement Warrants increased by $0.1 million and the fair value of the Unvested Founder Shares increased by $0.1 million. The increase was primarily due to the change in volatility and expected term over that period.

(Benefit) provision for income taxes

Net loss before income taxes for the three months ended September 30, 2023 of $31.0 million generated a benefit for income taxes of $6.9 million. Net income before income taxes for the three months ended September 30, 2022 of $9.0 million generated a benefit for income taxes of $10.7 million.

Net loss before income taxes for the nine months ended September 30, 2023 of $75.3 million generated a benefit for income taxes of $15.0 million. Net income before income taxes for the nine months ended September 30, 2022 of $87.3 million generated a provision for income taxes of $10.0 million.

The effective tax rate for the nine months ended September 30, 2023 differed from the statutory rate primarily due to stock compensation expense, non-deductible transaction costs due to the BST acquisition and state tax expense. The effective tax rate for the nine months ended September 30, 2022 differed from the statutory rate primarily due to a non-deductible mark-to-market liability, limitations on executive compensation and state tax expense.

Liquidity and Capital Resources

As of September 30, 2023, we had cash and cash equivalents of $107.6 million, which includes restricted cash of $6.3 million, and $442.1 million of loan availability under the revolving credit facility. As of September 30, 2023, we had four letters of credit totaling $7.9 million of utilization against the revolving credit facility. Three letters of credit are used to satisfy real estate lease agreements for three of our offices in lieu of security deposits in the amount of $1.8 million as of September 30, 2023 and December 31, 2022. The Company also has an irrevocable letter of credit to satisfy the obligations of a subsidiary in the amount of $6.1 million as of September 30, 2023 and zero as of December 31, 2022.

On February 27, 2023, the Company's Board of Directors approved a share repurchase program authorizing the Company to repurchase up to $100 million of its Class A common stock from time to time in open market transactions. The repurchase program was effective immediately and expires on December 31, 2023. As of September 30, 2023, the Company has repurchased its Class A common stock as part of this program using cash on hand for an aggregate amount of $13.1 million, including commissions.

On May 8, 2023, we paid cash consideration in an aggregate amount of $141.3 million, adjusted to $140.9 million as of September 30, 2023, for the acquisition of BST. We funded this cash consideration with cash on hand.

Our primary sources of liquidity are internally generated funds combined with our borrowing capacity under our revolving credit facility. We believe that these sources will provide sufficient liquidity for us to meet our working capital, capital expenditure and other cash requirements for at least the next twelve months. We may from time to time at our sole discretion, purchase, redeem, repay or retire our long-term debt, through tender offers, in privately negotiated or open market transactions or otherwise. We plan to finance our capital expenditures with cash from operations. Furthermore, our future liquidity and future ability to fund capital expenditures, working capital and debt requirements are also dependent upon our future financial performance, which is subject to many economic, commercial, financial and other factors that are beyond our control, including the ability of financial institutions to meet their lending obligations to us. If those factors significantly change, our business may not be able to generate sufficient cash flow from operations or future borrowings may not be available to meet our liquidity needs. We anticipate that to the extent we require additional liquidity as a result of these factors or in order to execute our strategy, it would be financed either by borrowings under our senior secured credit facilities, by other indebtedness, additional equity financings or a combination of the foregoing. We may be unable to obtain any such additional financing on reasonable terms or at all.

Cash Flow Summary

The following table is derived from our unaudited condensed consolidated statements of cash flows:

(in thousands)

Net cash flows provided by (used in): Nine Months Ended September 30, 2023 2022
Operating activities $144,018 $344,675
Investing activities $(218,449) $(78,920)
Financing activities $(158,514) $(12,314)

Cash Flows from Operating Activities

Cash flows from operating activities provided $144.0 million for the nine months ended September 30, 2023 and $344.7 million for the nine months ended September 30, 2022. This decrease of $200.7 million, or 58.2%, in cash flows from operating activities for the nine months ended September 30, 2023 was primarily the result of decreases in net income of $137.5 million, and negative changes in net working capital of $132.5 million, offset by increases in adjustments for non-cash items of $69.4 million.

The $69.4 million increase in non-cash items was primarily due increases in deferred income taxes of $51.6 million, increases in the (gain) loss on change in fair value of Private Placement Warrants and Unvested Founder Shares of $56.7 million, increases in depreciation of $5.4 million and increases in stock-based compensation of $2.1 million, and other net increases of $1.2 million, offset by gain on extinguishment of debt of $46.9 million and loss on disposal of property and equipment of $0.7 million.

During the nine months ended September 30, 2023, $1.3 million was used by changes in net working capital primarily due to increases in prepaid expenses and other assets of $0.8 million, increases in prepaid taxes of $5.2 million, decreases of $1.9 million of accounts payable, accrued expenses, legal contingencies and other, and decreases in operating lease obligations of $5.0 million, partially offset by decreases in accounts receivable of $11.6 million. The decreases of $1.9 million of accounts payable, accrued expenses, legal contingencies and other includes decreases of $21.5 million of accrued legal contingencies, and decreases of $2.0 million in accrued compensation expense primarily related to the Company's incentive compensation program, offset by increases in accrued interest of $18.5 million and increases in other accounts payable and accrued expenses of $3.1 million.

During the nine months ended September 30, 2022, $131.2 million was provided by changes in net working capital primarily due to increases in accounts payable and accrued expenses and other expenses of $89.7 million, decreases in prepaid expenses and other assets of $13.8 million, decreases in net accounts receivable of $27.6 million and decreases in prepaid taxes of $5.1 million, offset by decreases in operating lease obligations of $4.8 million. The increase in accounts payable and accrued expenses and other expenses of $89.7 million was primarily due to increases of $24.9 million of accrued interest, $39.8 million of accrued taxes, $3.5 million in accrued compensation expenses primarily related to the Company's incentive compensation program and $21.5 million of other accounts payable and accrued expenses.

Cash Flows from Investing Activities

For the nine months ended September 30, 2023, net cash of $218.4 million was used in investing activities including $77.5 million for purchases of property and equipment and capitalization of software development and $140.9 million for the acquisition of BST. For the nine months ended September 30, 2022, net cash of $78.9 million was used in investing activities including $64.2 million for purchases of property and equipment and capitalization of software development and the $15.0 million equity investment in Abacus.

Cash Flows from Financing Activities

Cash flows used in financing activities for the nine months ended September 30, 2023 were $158.5 million primarily consisting of $135.0 million for the repurchase of 5.750% Notes, $13.1 million purchase of treasury stock, including commissions, $9.9 million repayments of Term Loan B and $0.5 million of taxes paid on net settlement of vested share awards.

Cash flows used in financing activities for the nine months ended September 30, 2022 were $12.3 million consisting of $9.9 million repayments of Term Loan B and $2.4 million of taxes paid on net settlement of vested share awards.

Term Loans and Revolvers

On August 24, 2021, MPH issued new senior secured credit facilities composed of $1,325.0 million of Term Loan B, $450.0 million of Revolver B, and $1,050.0 million in aggregate principal amount of 5.50% Senior Secured Notes. MPH used the net proceeds from Term Loan B, issued with a discount of 1.00%, and the 5.50% Senior Secured Notes to repay all of the outstanding balance of its Term Loan G of $2,341.0 million, and pay fees and expenses in connection therewith. Term Loan B matures on September 1, 2028 and Revolver B matures on August 24, 2026.

Interest on Term Loan B and Revolver B was calculated, at MPH's option, as (a) Term SOFR (or, with respect to Term Loan B only, 0.50%, if higher), plus the applicable SOFR adjustment, plus the applicable margin, or (b) the highest rate of (1) the prime rate, (2) the federal funds effective rate, plus 0.50%, (3) the Term SOFR for an interest period of one month, plus the applicable SOFR adjustment, plus 1.00% and (4) 0.50% for Term Loan B and 1.00% for Revolver B, in each case, plus an applicable margin of 4.25% for Term Loan B and between 3.50% and 4.00% for Revolver B, depending on MPH's first lien debt to consolidated EBITDA ratio.

Prior to July 1, 2023, LIBOR was used to calculate the interest on Term Loan B and Revolver B. On September 12, 2023, the Company entered into interest rate swap agreements with a total notional value of $800 million to effectively convert a portion of its floating rate debt to a fixed-rate basis. The interest rate swap agreements are effective August 31, 2023 and mature on August 31, 2026. The principal objective of these contracts is to eliminate or reduce the volatility of the cash flows in interest payments associated with the Company's floating rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. The Company's interest rate swaps are highly effective at offsetting the changes in cash outflows and therefore designated as cash flow hedging instruments.

The interest rate in effect for Term Loan B was 9.92% and 7.32% as of September 30, 2023 and 2022, respectively.

We are obligated to pay a commitment fee on the average daily unused amount of our revolving credit facility. The annual commitment fee rate was 0.50% at September 30, 2023 and 0.25% at December 31, 2022. The fee can range from an annual rate of 0.25% to 0.50% based on our leverage ratio, as defined in the agreement.

Senior Notes

On October 8, 2020, the Company issued $1,300.0 million in aggregate principal amount of Senior Convertible PIK Notes. The Senior Convertible PIK Notes were issued with a 2.5% discount with a maturity date of October 15, 2027.

The Senior Convertible PIK Notes are convertible into shares of Class A common stock based on a $13.00 conversion price, subject to customary anti-dilution adjustments. The interest rate on the Senior Convertible PIK Notes is fixed at 6% in cash and 7% in kind, and is payable semi-annually on April 15 and October 15 of each year.

On October 29, 2020, the Company issued $1,300.0 million in aggregate principal amount of the 5.750% Notes. The 5.750% Notes are guaranteed on a senior unsecured basis jointly and severally by the Company and its subsidiaries and have a maturation date of November 1, 2028. The 5.750% Notes were issued at par. The interest rate on the 5.750% Notes is fixed at 5.750%, and is payable semi-annually on May 1 and November 1 of each year.

On August 24, 2021 MPH issued $1,050.0 million in aggregate principal amount of 5.50% Senior Secured Notes with a maturation date of September 1, 2028. The interest rate on the 5.50% Senior Secured Notes is fixed at 5.50%, and is payable semi-annually on March 1 and September 1 of each year. The 5.50% Senior Secured Notes are guaranteed and secured as described below under "Guarantees and Security".

During 2022, the Company repurchased and cancelled $136.2 million of the 5.750% Notes, resulting in the recognition of a gain on debt extinguishment of $34.6 million for the year ended December 31, 2022.

During the nine months ended September 30, 2023, the Company repurchased and cancelled $184.0 million of the 5.750% Notes, resulting in the recognition of a gain on debt extinguishment of $46.9 million.

Debt Covenants and Events of Default

We are subject to certain affirmative and negative debt covenants under the debt agreements governing our indebtedness that limit our and/or certain of our subsidiaries' ability to engage in specific types of transactions. These covenants limit our and/or certain of our subsidiaries' ability to, among other things:

  • incur additional indebtedness or issue disqualified or preferred stock;
  • pay certain dividends or make certain distributions on capital stock or repurchase or redeem capital stock;
  • make certain loans, investments or other restricted payments;
  • transfer or sell certain assets;
  • incur certain liens;
  • place restrictions on the ability of its subsidiaries to pay dividends or make other payments to us;
  • guarantee indebtedness or incur other contingent obligations;
  • prepay junior debt and make certain investments;
  • consummate any merger, consolidation or amalgamation, or liquidate, wind up or dissolve itself (or suffer any liquidation or dissolution), or dispose of all or substantially all of its business units, assets or other properties; and
  • engage in transactions with our affiliates.

Certain covenants related to the 5.50% Senior Secured Notes will cease to apply to the 5.50% Senior Secured Notes for so long as such notes have investment grade ratings from both Moody’s Investors Service, Inc. and S&P Global Ratings.

The Revolver Ratio is such that, if, as of the last day of any fiscal quarter of MPH, the aggregate amount of loans under the revolving credit facility, letters of credit issued under the revolving credit facility (to the extent not cash collateralized or backstopped or, in the aggregate, in excess of $10.0 million) and swingline loans are outstanding and/or issued in an aggregate amount greater than 35% of the total commitments in respect of the revolving credit facility at such time, the revolving credit facility will require MPH to maintain a maximum first lien secured leverage ratio of 6.75 to 1.00. Our consolidated first lien debt to consolidated EBITDA ratio is 3.63 times, 2.32 times, and 2.64 times as of September 30, 2023, September 30, 2022, and December 31, 2022, respectively.

As of September 30, 2023 and December 31, 2022 we were in compliance with all of the debt covenants.

The debt agreements governing the senior secured credit facilities, the 5.750% Notes and the 5.50% Senior Secured Notes contain customary events of default, subject to grace periods and exceptions, which include, among others, payment defaults, cross-defaults to certain material indebtedness, certain events of bankruptcy, material judgments, in the case of the debt agreements governing the senior secured credit facilities and the 5.50% Senior Secured Notes, failure of a guarantee on the liens on material collateral to remain in effect, in the case of the debt agreements governing the senior secured credit facilities, any change of control. Upon the occurrence of an event of default under such debt agreements, the lenders and holders of such debt will be permitted to accelerate the loans and terminate the commitments, as applicable, thereunder and exercise other specified remedies available to the lenders and holders thereunder.

See the footnotes to the EBITDA and Adjusted EBITDA reconciliation table provided above under "Non-GAAP Financial Measures" for material differences between the financial information of MultiPlan and MPH.

Guarantees and Security

All obligations under the debt agreements governing the senior secured credit facilities and the 5.50% Senior Secured Notes are unconditionally guaranteed by MPH Acquisition Corp. 1, the direct holding company parent of MPH, and each existing and subsequently acquired or organized direct or indirect wholly owned U.S. organized restricted subsidiary of MPH (subject to certain exceptions). All such obligations, and the guarantees of such obligations, are secured, subject to permitted liens and other exceptions, by a first priority lien shared between the senior secured credit facilities and the 5.50% Senior

Secured Notes on substantially all of MPH’s and the subsidiary guarantors’ tangible and intangible property, and a pledge of all of the capital stock of each of their respective subsidiaries.

Critical Accounting Policies

In preparing our Unaudited Condensed Consolidated Financial Statements, we are required to make judgments, assumptions and estimates, which we believe are reasonable and prudent based on the available facts and circumstances. These judgments, assumptions and estimates affect certain of our revenues and expenses and their related balance sheet accounts and disclosure of our contingent liabilities. We base our assumptions and estimates primarily on historical experience and consider known and projected trends. On an ongoing basis, we re-evaluate our selection of assumptions and the method of calculating our estimates. Actual results, however, may materially differ from our calculated estimates, and this difference would be reported in our current operations.

For a detailed description of our critical accounting estimates, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 in our 2022 Annual Report. For a detailed discussion of our significant accounting policies, see Note 2 of Notes to the Consolidated Financial Statements in Part II, Item 8, “Financial Statements and Supplementary Data” in our 2022 Annual Report.

During the three months ended September 30, 2023, we added a derivative policy related to interest rate swap agreements we entered into during the quarter. See Note 1 General Information and Basis of Accounting of the Notes to the unaudited condensed consolidated financial statements included in this Quarterly Report for additional information.

Customer Concentration

Three customers individually accounted for 32%, 20% and 10% of revenues for the year ended December 31, 2022. The loss of the business of one or more of our larger customers could have a material adverse effect on our results of operations. For further discussion on our customer concentration, please refer to Item 1A. “Risk Factors” in our 2022 Annual Report.

Recent Accounting Pronouncements

See Note 1 General Information and Basis of Accounting of the Notes to the unaudited condensed consolidated financial statements included in this Quarterly Report for additional information.

Quantitative and Qualitative Disclosure About Market Risk

See Item 3. Quantitative and Qualitative Disclosure about Market Risk below.

Internal Controls Over Financial Reporting

For further information on the Company’s internal controls over financial reporting see Item 4. Controls and Procedures.

Market risk

As filed, 254 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Reference is made to our 2022 Annual Report and in particular Item 7A.“Quantitative and Qualitative Disclosure about Market Risk” therein. As of September 30, 2023, there were no material changes in the market risks described in our 2022 Annual Report.

Controls and procedures

As filed, 1,959 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Company’s principal executive officer and principal financial and accounting officer, the Company conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.

Based on this evaluation, our principal executive officer and principal financial and accounting officers have concluded that, as of September 30, 2023, our disclosure controls and procedures were designed at a reasonable assurance level and were effective to provide reasonable assurance that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officers, as appropriate, to allow timely decisions regarding required disclosures.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting during the nine months ended September 30, 2023 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Management recognizes that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected.

Risk factors

As filed, 190 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes during the nine months ended September 30, 2023 to the risk factors previously disclosed in Item 1A. “Risk Factors” in the Company's 2022 Annual Report.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-07-01 to 2023-09-30$242.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2023-01-01 to 2023-09-30$717.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Operating income3 months2023-07-01 to 2023-09-30$39.5mus-gaap:OperatingIncomeLoss
Operating income9 months2023-01-01 to 2023-09-30$121.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-07-01 to 2023-09-30$84.3mus-gaap:InterestExpense
Interest expense9 months2023-01-01 to 2023-09-30$250.2mus-gaap:InterestExpense
Income tax3 months2023-07-01 to 2023-09-30−$6.9mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2023-01-01 to 2023-09-30−$15.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-07-01 to 2023-09-30−$24.1mus-gaap:NetIncomeLoss
Net income9 months2023-01-01 to 2023-09-30−$60.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-07-01 to 2023-09-30−$0.04us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2023-01-01 to 2023-09-30−$0.09us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-07-01 to 2023-09-30−$0.04us-gaap:EarningsPerShareBasic
Basic EPS9 months2023-01-01 to 2023-09-30−$0.09us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-07-01 to 2023-09-30646,443,806 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2023-01-01 to 2023-09-30643,855,782 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2023-01-01 to 2023-09-30$144.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2023-01-01 to 2023-09-30$77.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2023-01-01 to 2023-09-30$13.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2023-09-30$101.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-09-30$211.7mus-gaap:AssetsCurrent
Total assetsAt period end2023-09-30$7.06bnus-gaap:Assets
Current liabilitiesAt period end2023-09-30$171.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-09-30$5.31bnus-gaap:Liabilities
Current portion of debtAt period end2023-09-30$13.3mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2023-09-30$1.75bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001793229-23-000122. Last ingested by Listed: Nov 15, 2026, 00:46 ET. Listed shows no prices and gives no investment advice.